Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andrieu

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Journal of Neuro-Oncology|June 20, 2003
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiformeStéphane Oudard, Antoine Carpentier, Eugeniu Banu, et al.
European Journal of Cancer|June 1, 1980
HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subsJ Hors, G Steinberg, J M Andrieu, et al.
Bulletin Du Cancer|January 1, 1981
[Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)]J M Andrieu, B Asselain, C Bayle, et al.
Leukemia & Lymphoma|March 1, 1996
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapyN Ifrah, M Hunault, J P Jais, et al.
European Journal of Cancer|February 1, 1979
The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trialJ M Andrieu, C Bayle-Weisgerber, M Boiron, et al.
The Journal of Infectious Diseases|March 1, 1990
Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factorsD Khayat, C Soubrane, J M Andrieu, et al.
The Journal of Investigative Dermatology|March 12, 2002
Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligoF A Le Gal, M F Avril, J Bosq, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patientsS Oudard, E Banu, F Scotte, et al.
Clinical Immunology and Immunopathology|May 1, 1988
Effects of cyclosporin on T-cell subsets in human immunodeficiency virus diseaseJ M Andrieu, P Even, A Venet, et al.
European Journal of Haematology|October 1, 1987
Hodgkin's disease, clinical stages IA to IIIB: combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen). Six-year resultsP Colonna, J M Andrieu, R Ghouadni, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Journal of Neuro-Oncology|June 20, 2003
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiformeStéphane Oudard, Antoine Carpentier, Eugeniu Banu, et al.
European Journal of Cancer|June 1, 1980
HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subsJ Hors, G Steinberg, J M Andrieu, et al.
Bulletin Du Cancer|January 1, 1981
[Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)]J M Andrieu, B Asselain, C Bayle, et al.
Leukemia & Lymphoma|March 1, 1996
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapyN Ifrah, M Hunault, J P Jais, et al.
European Journal of Cancer|February 1, 1979
The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trialJ M Andrieu, C Bayle-Weisgerber, M Boiron, et al.
The Journal of Infectious Diseases|March 1, 1990
Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factorsD Khayat, C Soubrane, J M Andrieu, et al.
The Journal of Investigative Dermatology|March 12, 2002
Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligoF A Le Gal, M F Avril, J Bosq, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patientsS Oudard, E Banu, F Scotte, et al.
Clinical Immunology and Immunopathology|May 1, 1988
Effects of cyclosporin on T-cell subsets in human immunodeficiency virus diseaseJ M Andrieu, P Even, A Venet, et al.
European Journal of Haematology|October 1, 1987
Hodgkin's disease, clinical stages IA to IIIB: combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen). Six-year resultsP Colonna, J M Andrieu, R Ghouadni, et al.
Pageof 18